Search results for "AGGREGATION"

showing 10 items of 566 documents

Hydrated Layer Formation on Tricalcium and Dicalcium Silicate Surfaces: Experimental Study and Numerical Simulations

2001

In this paper, an original approach is used to study the calcium silicate hydrate (C−S−H) layer formation on the surface of grains of anhydrous silicate during tricalcium and dicalcium silicate hydration from the variation of the rate of hydration with lime concentration. The effects of C−S−H nucleation and growth on the curves for the degree of reaction against time have been separated in both experimental study of the rate of hydration in controlled conditions and numerical simulation of the growth of C−S−H on a surface from a particle aggregation model. The influence of the number of nuclei and of the different growth modes has been quantified.

Degree of reactionMaterials scienceNucleationMineralogySurfaces and Interfacesengineering.materialCondensed Matter PhysicsSilicatechemistry.chemical_compoundParticle aggregationchemistryChemical engineeringElectrochemistryAnhydrousengineeringGeneral Materials ScienceCalcium silicate hydrateLayer (electronics)SpectroscopyLimeLangmuir
researchProduct

Impact of Demand Response Control Logic on Isolated Island's Distribution Networks

2019

The work presents the results of a study regarding the impact of some Demand Response control logics on an isolated distribution network. The proposed control is divided into precise steps in which the coordination between the general aggregator controller and the single local Energy Management Systems is developed and illustrated with details. The control is applied to the flexible loads and to the storage systems of photovoltaic plants installed at the end-users' houses and connected to the network. The study is carried out delivering a suitable network model of the island's system, with the implementation of load profiles for all the loads of the network for a total simulation time of 24…

Demand responseelectric storageComputer scienceEnergy managementPhotovoltaic systemControl (management)demand response; EES; electric storage; flexible loads; load aggregation; photovoltaic; PV; small islandsflexible loadsload aggregationControl engineeringPVcomputer.software_genresmall islandsEESNews aggregatorphotovoltaicSettore ING-IND/33 - Sistemi Elettrici Per L'EnergiaDemand responseflexible loadControl theoryControl logiccomputerNetwork model2019 IEEE 5th International forum on Research and Technology for Society and Industry (RTSI)
researchProduct

Detergent Properties Influence the Stability of the Glycophorin A Transmembrane Helix Dimer in Lysophosphatidylcholine Micelles

2012

AbstractDetergents might affect membrane protein structures by promoting intramolecular interactions that are different from those found in native membrane bilayers, and fine-tuning detergent properties can be crucial for obtaining structural information of intact and functional transmembrane proteins. To systematically investigate the influence of the detergent concentration and acyl-chain length on the stability of a transmembrane protein structure, the stability of the human glycophorin A transmembrane helix dimer has been analyzed in lyso-phosphatidylcholine micelles of different acyl-chain length. While our results indicate that the transmembrane protein is destabilized in detergents w…

DetergentsMolecular Sequence DataBiophysicsMicelleProtein Structure SecondaryCell membraneHydrophobic mismatchmedicineHumansGlycophorinAmino Acid SequenceGlycophorinsLipid bilayerMicellesAggregation numberDose-Response Relationship DrugbiologyChemistryCell MembraneMembraneLysophosphatidylcholinesTransmembrane proteinTransmembrane domainmedicine.anatomical_structureBiochemistrybiology.proteinBiophysicslipids (amino acids peptides and proteins)Protein MultimerizationHydrophobic and Hydrophilic InteractionsBiophysical Journal
researchProduct

General aggregation operators based on a fuzzy equivalence relation in the context of approximate systems

2016

Our paper deals with special constructions of general aggregation operators, which are based on a fuzzy equivalence relation and provide upper and lower approximations of the pointwise extension of an ordinary aggregation operator. We consider properties of these approximations and explore their role in the context of extensional fuzzy sets with respect to the corresponding equivalence relation. We consider also upper and lower approximations of a t-norm extension of an ordinary aggregation operator. Finally, we describe an approximate system, considering the lattice of all general aggregation operators and the lattice of all fuzzy equivalence relations.

Discrete mathematicsPointwiseLogic05 social sciencesFuzzy set050301 educationContext (language use)02 engineering and technologyExtension (predicate logic)Lattice (discrete subgroup)Operator (computer programming)Artificial Intelligence0202 electrical engineering electronic engineering information engineeringEquivalence relationApplied mathematics020201 artificial intelligence & image processing0503 educationOrdered weighted averaging aggregation operatorMathematicsFuzzy Sets and Systems
researchProduct

Blue autofluorescence in protein aggregates “lighted on” by UV induced oxidation

2019

Oxidation of amino acid side chains in protein structure can be induced by UV irradiation leading to critical changes in molecular structure possibly modifying protein stability and bioactivity. Here we show, by using a combination of multiple spectroscopic techniques and Fluorescence Lifetime Imaging, that UV-light exposure induces irreversible oxidation processes in Ubiquitin structure. In particular, the growth of a new autofluorescence peak in the blue region is detected, that we attribute to tyrosine oxidation products. Blue autofluorescence intensity is found to progressively increase also during aggregation processes leading to the formation of aggregates of non-amyloid nature. Signi…

Dityrosine formation0301 basic medicineAmyloidUltraviolet RaysBiophysicsPeptideProtein aggregationAmyloid autofluorescence; Dityrosine formation; Fluorescence lifetime imaging; Oxidative stress; UbiquitinFluorescence lifetime imagingBiochemistryFluorescenceAnalytical ChemistryProtein Aggregates03 medical and health sciences0302 clinical medicineProtein structureHumansTyrosineMolecular Biologychemistry.chemical_classificationAmyloid beta-PeptidesUbiquitinChemistryFluorescenceAmino acidAutofluorescence030104 developmental biologyBiophysicsOxidative streAmyloid autofluorescenceOxidation-Reduction030217 neurology & neurosurgeryBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics
researchProduct

In vitro and in vivo characterization of a new organic nitrate hybrid drug covalently bound to pioglitazone.

2014

<b><i>Background/Aims:</i></b> Organic nitrates represent a group of nitrovasodilators that are clinically used for the treatment of ischemic heart disease. The new compound CLC-3000 is an aminoethyl nitrate (AEN) derivative of pioglitazone, a thiazolidinedione antidiabetic agent combining the peroxisome proliferator-activated receptor γ agonist activity of pioglitazone with the NO-donating activity of the nitrate moiety. <b><i>Methods:</i></b> In vitro and in vivo characterization was performed by isometric tension recording, platelet function, bleeding time and detection of oxidative stress. <b><i>Results:</i></…

DrugBlood PlateletsMaleBleeding TimePlatelet Aggregationmedia_common.quotation_subjectVasodilator Agentsmedicine.disease_causeMitochondria Heartchemistry.chemical_compoundNitrateFibrinolytic AgentsIn vivomedicineAnimalsHumansHypoglycemic AgentsRats WistarAortamedia_commonPharmacologyNitratesPioglitazoneChemistryGeneral MedicineReactive Nitrogen SpeciesIn vitroOrganic nitratesMice Inbred C57BLVasodilationBiochemistryCovalent bondVasoconstrictionThiazolidinedionesReactive Oxygen SpeciesPioglitazoneOxidative stressmedicine.drugPharmacology
researchProduct

Could resveratrol be a useful drug for the treatment of malignant hemopathies?

2013

Resveratrol is a poly-phenol with many beneficial effects: not only as an antioxidant, anti-inflammatory, and antiatherogenic agent, as well as a platelet aggregation inhibitor, but also as an antiproliferative and proapoptotic factor in various types of cancers. There are reviews about the mechanisms responsible for its effects in leukemia and lymphomas, emphasizing the chemosensitizing role of resveratrol, which allows overcoming the multidrug resistance of cancers. The action of resveratrol occurs preferentially on leukemic cells, and not on the normal ones. In addition, it is one of the few drugs that act on leukemic stem cells. If experimental results are promising, its application in …

DrugCancer Researchmedicine.medical_treatmentmedia_common.quotation_subjectAntineoplastic AgentsPharmacologyResveratrolAntioxidantsPatents as Topicchemistry.chemical_compoundNeoplasmsDrug DiscoveryStilbenesmedicineHumansPharmacology (medical)Antiatherogenic agentmedia_commonbusiness.industryGeneral Medicinemedicine.diseaseAntineoplastic Agents PhytogenicBioavailabilityLeukemiaOncologychemistryResveratrolHematologic NeoplasmsPlatelet aggregation inhibitorDrug Therapy CombinationStem cellbusinessAdjuvantRecent patents on anti-cancer drug discovery
researchProduct

Number of drugs used in secondary cardiovascular prevention and late survival in the population of Valencia Community, Spain.

2019

Abstract Background Drug treatment for secondary prevention of cardiovascular disease is recommended by guidelines, but it is not always followed in real life. This study wanted to assess the size of this gap and its impact on mortality in subjects after a cardiovascular event (MACE). Methods Patients with any of MACE in the period from January 1st 2011 to December 31st 2013, and more than one year of follow-up were selected from population of the Valencian Community. Drugs for secondary prevention were antiplatelets, renin-angiotensin system blockers and statins. Assessment of treatment was performed one year after the initial event. Mortality risk was assessed using Cox by the number of d…

DrugMalemedicine.medical_specialtyMedication Therapy Managementmedia_common.quotation_subjectmedicine.medical_treatmentPopulationMyocardial InfarctionAngiotensin-Converting Enzyme InhibitorsDisease030204 cardiovascular system & hematologyRevascularizationRisk Assessment03 medical and health sciencesAngiotensin Receptor Antagonists0302 clinical medicineInternal medicinemedicineSecondary PreventionHumans030212 general & internal medicineMyocardial infarctioneducationStrokemedia_commonAgededucation.field_of_studybusiness.industryConfoundingmedicine.diseaseSurvival AnalysisProfessional Practice GapsStrokeSpainFemaleHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessMacePlatelet Aggregation InhibitorsInternational journal of cardiology
researchProduct

Biowaiver monograph for immediate-release solid oral dosage forms: acetylsalicylic acid.

2012

A biowaiver monograph for acetylsalicylic acid (ASA) is presented. Literature and experimental data indicate that ASA is a highly soluble and highly permeable drug, leading to assignment of this active pharmaceutical ingredient (API) to Class I of the Biopharmaceutics Classification System (BCS). Limited bioequivalence (BE) studies reported in the literature indicate that products that have been tested are bioequivalent. Most of the excipients used in products with a marketing authorization in Europe are not considered to have an impact on gastrointestinal motility or permeability. Furthermore, ASA has a wide therapeutic index. Thus, the risks to the patient that might occur if a nonbioequi…

Drugmedia_common.quotation_subjectPharmaceutical ScienceAdministration OralBiological AvailabilityPharmacologyBioequivalenceMarketing authorizationDosage formDrug StabilityFibrinolytic AgentsAnimalsHumansCyclooxygenase Inhibitorsmedia_commonActive ingredientAspirinChemistryAnti-Inflammatory Agents Non-SteroidalBiopharmaceutics Classification SystemSolubilityTherapeutic EquivalencyPlatelet aggregation inhibitorCaco-2 CellsFibrinolytic agentPlatelet Aggregation InhibitorsTabletsJournal of pharmaceutical sciences
researchProduct

Tendencia en la utilización de antiagregantes en la Comunidad Valenciana (2000-2005)

2007

Beatriz Román Llamosí, Rocío Broseta Solaz, Joan Quiles Izquierdo y Amalia Úbeda Pascual (Amalia.Ubeda@uv.es) Los antiagregantes plaquetarios son fármacos básicos para la prevención de enfermedades isquémicas arteriales. El objetivo de este trabajo es conocer la evolución de su utilización en Atención Primaria en la Comunidad Valenciana durante el periodo 2000-2005. Métodos: Estudio descriptivo del consumo de los antiagregantes plaquetarios (código ATC: B01AC) dispensados con cargo al Sistema Nacional de Salud en la Comunidad Valenciana en el ámbito de Atención Primaria. Datos expresados en dosis diarias definidas (DDD) por 1.000 habitantes y día. Resultados: En 2005 tres fármacos represent…

Drugmedicine.medical_specialtyArterial diseasemedia_common.quotation_subjectlcsh:MedicinePrimary careUNESCO::CIENCIAS MÉDICAS ::Salud públicaInternal medicineAntiagregantes plaquetarios:CIENCIAS MÉDICAS ::Salud pública [UNESCO]MedicineUtilización de medicamentosmedia_commonNational healthbusiness.industryIncidence (epidemiology)lcsh:Public aspects of medicineÁcido acetilsalicícicolcsh:Rlcsh:RA1-1270General MedicineClopidogrelClopidogrelSurgeryPlatelet aggregation inhibitorTriflusalbusinessAntiagregantes plaquetarios; Clopidogrel; Ácido acetilsalicícico; Utilización de medicamentosmedicine.drug
researchProduct